This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Stanley Fahn, MD; George Craddock, MD; Gerald Kumin, MD

Arch Neurol. 1971;25(1):45-48.

Abstract
The ingestion of 28 capsules (2.8 gm) of amantadine hydrochloride by a patient with postencephalitic parkinsonism in an attempt at suicide caused an acute toxic psychosis, urinary retention, and a mixed acid-base disturbance. The pupils were slightly dilated, but there was no decrease in the level of consciousness. Convulsions did not occur, possibly because he had been receiving diphenylhydantoin. The patient recovered within four days of treatment with hydration; in addition, chlorpromazine was found to have a calming effect. Measurement of amantadine in the urine showed the biological half-life of the drug to be 28 hours. The cerebrospinal fluid to blood ratio of amantadine concentrations was 0.52, indicating the existence of a blood-brain barrier for this nonmetabolized drug.

Author Affiliations
Philadelphia

From the departments of neurology (Dr. Fahn) and medicine (Drs. Craddock and Kumin), University of Pennsylvania School of Medicine, Philadelphia.

Footnotes
Accepted for publication Feb 2, 1971.

Reprint requests to Department of Neurology, University of Pennsylvania Hospital, Philadelphia 19104 (Dr. Fahn).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Amantadine Hydrochloride Pharmacokinetics in Hemodialysis Patients
SOUNG et al.
ANN INTERN MED 1980;93:46-49.
ABSTRACT  

Amantadine in Parkinson's Disease: Review of More Than Two Years' Experience
Schwab et al.
JAMA 1972;222:792-795.
ABSTRACT